other

【Product name】Cleviprex

[English common name]Clevidipine

[Chinese common name]Cloweidipine butyrate

[English name]

[Chinese other name]

[Indications] For the treatment of hypertension that is not suitable for oral or oral administration, it can also be used to treat acute blood pressure after surgery.

[Usage and Dosage] Monitoring
When injecting this product, the patient's blood pressure and heart rate should be continuously monitored until the patient's signs are stable. For patients who continue to infuse this product for a long time and have not switched to other antihypertensive drugs, at least 8 hours of rebound hypertensive hypertension monitoring should be performed after the end of the infusion. Such patients may require follow-up adjustments in blood pressure control.
Recommended dose
This product is an intravenous drug preparation, the dosage should be gradually adjusted during use to achieve the desired antihypertensive effect. The specific dose depends on the expected antihypertensive effect and the patient's response.
Starting dose:
The initial dose of intravenous infusion of this product is l ~ 2mg / hour.
Dose adjustment:
The dose can be doubled at intervals of a short time (90 seconds). When approaching the target antihypertensive effect, the increased dose should be less than double, and the time interval for adjusting the dose should be extended to 5 to 10 minutes. In general, for every 1-2 mg/hour increase in dose, the systolic blood pressure can be further reduced by 2 to 4 mmHg.
Maintenance dose:
Most patients achieve a desired therapeutic response by measuring 4 to 6 mg/hour. For patients with severe hypertension, it may be necessary to increase the dose to 32 mg / hour, but the clinical experience of this dose is limited.
Maximum dose:
The maximum dose for most patients does not exceed 16 mg/hour. Short-term medication experience with a dose of 32 mg/hour is limited. Due to the limitation of lipid intake, it is recommended that the infusion of this product within 24 hours does not exceed 1000m1 or an average of 21mg/hr. In clinical studies, 55 hypertensive patients received more than 500 ml of this product within 24 hours. Almost no infusion of this product (all doses) more than 72 hours of medication experience.
Switch to other antihypertensive drugs:
When determining the appropriate oral antihypertensive drug, you can stop using this product or gradually reduce the dose of this product. In the initial stage of oral antihypertensive drugs, the delay time of oral drug onset should be considered. Blood pressure should continue to be monitored until the desired effect is achieved.

[Storage] The 50 mL expiration date is the ML filling size (2-8oC) at the time of refrigerated storage for 24 months. 100mL can be obtained for 36 months of shelf life, and the filling size when stored in cold storage. Both configurations can store up to 2 months of control room temperature as "in use" storage.

[Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

【Product name】RISPERDAL

[English common name]Risperidone Tablets

[Chinese common name]Wisdom

[English name]3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1

[Chinese other name]3-[2- [4-(6-fluoro-1,2-benzisoxazole-3-yl)

[indications]
Risperidone orally disintegrating tablets: for the treatment of acute and chronic schizophrenia and other obvious symptoms of various psychiatric conditions (such as: hallucinations, delusions, thinking disorders, hostility, suspicion) and obvious negative symptoms (such as : slow response, apathy and social apathy, less language). It can also alleviate the emotional symptoms associated with schizophrenia (eg depression, guilt, anxiety). For patients who are effective in the acute phase of treatment, this product can continue to exert its clinical efficacy during the maintenance period.
Risperidone oral solution:
1. Obvious positive symptoms (such as hallucinations, delusions, thinking disorders, hostility, suspicion) and obvious negative symptoms (such as unresponsiveness, apathy, and socialization) for the treatment of acute and chronic schizophrenia and various other psychiatric conditions. Indifferent, less language). It can also alleviate the emotional symptoms associated with schizophrenia (eg depression, guilt, anxiety). For patients who are effective in the acute phase of treatment, this product can continue to exert its clinical efficacy during the maintenance period.
2. It can be used to treat manic episodes of bipolar disorder, which is characterized by high mood, exaggeration or irritability, high self-evaluation, reduced sleep requirements, accelerated speech, free thinking, distraction or low judgment. Including disorder or excessive behavior).
Risperidone dispersible tablets:
1. For the treatment of acute and chronic schizophrenia and other symptoms of various psychiatric states.
2. For patients who are effective in the acute phase of treatment, in the maintenance period, Wisdom can continue to play its clinical efficacy.
3. It can be used to treat manic episodes of bipolar disorder, which is characterized by high mood, exaggeration or irritability, decreased sleep requirements, increased speech rate, distracted attention or low judgment (including disorder or excessive behavior).
Risperidone capsules: obvious positive symptoms (eg, hallucinations, delusions, thinking disorders, hostility, suspicion) and obvious negative symptoms (eg, unresponsiveness) for the treatment of acute and chronic schizophrenia and various other psychotic conditions , apathy and social indifference, less language). It can also alleviate the emotional symptoms associated with schizophrenia (eg depression, guilt, anxiety). For patients who are effective in the acute phase of treatment, this product can continue to exert its clinical efficacy during the maintenance period.
Risperidone tablets:
1. Obvious positive symptoms (such as hallucinations, delusions, thinking disorders, hostility, suspicion) and obvious negative symptoms (such as unresponsiveness, apathy and socialization) for the treatment of acute and chronic schizophrenia and various other psychotic conditions Indifferent, less language). It can also alleviate the emotional symptoms associated with schizophrenia (eg depression, guilt, anxiety). For patients who are effective in the acute phase of treatment, this product can continue to exert its clinical efficacy during the maintenance period.
2. It can be used to treat manic episodes of bipolar disorder, which is characterized by high mood, exaggeration or irritability, high self-evaluation, reduced sleep requirements, accelerated speech, free thinking, distracted or low judgment ( Including disorder or excessive behavior).
Risperidone microspheres for injection: This product is used to treat acute and chronic schizophrenia and other obvious symptoms of various psychiatric conditions (such as hallucinations, delusions, thinking disorders, hostility, suspicion) and obvious negative symptoms ( Such as slow response, emotional apathy and social apathy, less words). It can alleviate the emotional symptoms associated with schizophrenia (such as depression, guilt, anxiety).

【Dosage】
Risperidone orally disintegrating tablets: The risperidone orally disintegrating tablet is placed on the tongue when taken, and will disintegrate itself within a few seconds and swallow into the stomach with saliva. It can be swallowed without using water (it can also be swallowed with water) . Those who use this antipsychotic to switch to this product should stop using the original antipsychotic when starting use. If the patient originally used a long-acting injection of antipsychotic drugs, the drug should be replaced with the drug at the time of the next injection. Re-assessment should be performed periodically if the used anti-Parkinson's disease drugs need to continue to be used. Adult: 1 time a day or 2 times a day. The recommended starting dose is twice a day, once 1mg, the next day is increased to two times a day, once 2mg; if it can be tolerated, the third day can be increased to two times a day, each time 3mg.
Risperidone Oral Solution: For schizophrenia, use other antipsychotics to switch to this product: When starting to use, you should gradually stop using the original antipsychotic. If the patient originally used a long-acting antipsychotic, this product can be replaced with this product. Whether the used anti-Parkinson's syndrome drugs need to be continued should be reassessed periodically. Adult: 1 time a day or 2 times a day. The recommended starting dose is twice a day, once 1mg, the next day is increased to twice a day, once 2mg; if it can be tolerated, the third day can be increased to two times a day, each time 3mg, after which, can be maintained This dose is unchanged or further adjusted according to individual circumstances.
Risperidone Dispersible Tablets: Patients with schizophrenia who have switched to other products using other antipsychotic drugs: When starting to use, the original antipsychotic should be discontinued. If the patient originally used a long-acting antipsychotic, risperidone could be used instead of the next course of treatment. If the drug used for Parkinson's syndrome needs to continue, it should be reassessed periodically. 1 time a day or 2 times a day. The initial measurement of 1mg, gradually increase the dose to 2 ~ 4mg per day for about 1 week, and gradually increase to 4 ~ 6mg per day in the second week. Thereafter, the dose can be maintained or further adjusted according to individual circumstances. In general, the optimum dose is 2 to 6 mg per day. The daily dose generally does not exceed 10 mg.
Risperidone capsules: those who use other antipsychotics to switch to this product: When starting to use, the original antipsychotic should be discontinued. If the patient originally used a long-acting injection of antipsychotic drugs, the drug should be replaced with the drug at the time of the next injection. Re-assessment should be performed periodically if the used anti-Parkinson's disease drugs need to continue to be used. Adult: 1 time a day or 2 times a day. The recommended starting dose is twice a day, once 1mg, the next day is increased to two times a day, once 2mg; if it can be tolerated, the third day can be increased to two times a day, each time 3mg. Thereafter, the dose can be maintained or further adjusted according to individual circumstances.
Risperidone tablets: those who use other antipsychotics to switch to this product: When starting to use, the original antipsychotic should be discontinued. If the patient originally used a long-acting antipsychotic, risperidone could be used instead of the next course of treatment. If the drug used for Parkinson's syndrome needs to continue, it should be reassessed periodically. 1. Adult: The dose should be gradually increased to twice a day for 3 days (3 tablets). For patients with acute or chronic schizophrenia, the starting dose should be twice a day, 1 mg (1 tablet). The next day should be increased to twice a day, 2mg (2 tablets). The third day should be increased to twice a day, once 3mg (3 tablets).
Risperidone microspheres for injection: The product should be injected once every 2 weeks using the attached injection needle and deep intramuscular injection of the buttocks. Should be alternately injected on the left and right sides of the half hip. Do not administer intravenously. See the usage and operation guide.
1. The recommended dose for adults is 25 mg intramuscularly, once every 2 weeks. Some patients may require higher doses, such as 37.5 mg or 50 mg. The 75 mg dose is not clinically significant. Do not recommend a dose higher than 50 mg every 2 weeks. Adequate antipsychotic medication should be guaranteed during the 3 week delay period after the first injection of this product (see the Pharmacokinetics section). The frequency of dose upregulation must not exceed once every 4 weeks. The effect of dose adjustment could not be predicted within 3 weeks after the first use of the adjusted higher dose injection.

[Storage]
Risperidone orally disintegrating tablets: sealed and stored in a cool (not more than 20 ° C) dry place.
Risperidone oral solution: Store at 15~30 °C, do not freeze.
Risperidone dispersible tablets: sealed and placed in a cool place.
Risperidone capsules: sealed and preserved.
Risperidone tablets: sealed at 15-30 ° C.
Risperidone microspheres for injection: sealed.

[Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

【Product name】Pulmicort

[English common name]Budesonide

[Chinese common name]Linaclotide

[English name]Budesonide

[Chinese other name]Linalotide acetate

[Indications] Constipation Irritable Bowel Syndrome (IBS-C), chronic idiopathic constipation (CIC).

【Dosage】
(1) IBS-C: 290 μg orally once a day
(2) CIC: 145 μg orally once a day
(3) Take the first meal at least 30 minutes before taking the stomach.

[Storage] Store at 25 ° C (77 ° F); go out between 15 ° C and 30 ° C (59 ° F and 86 ° F) [see USP control room temperature].
Keep LINZESS in the original container. Do not pack or repack. Protect against moisture. Do not remove the desiccant from the container. Keep the bottle closed in a dry place.

[Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.